CLINICAL_TRIALS
trial_result
· 2020-09-21
Clinical Trial Update: A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers [Phase 2]
Summary
Phase 2 trial comparing placebo to enzastaurin for lung cancer prevention in former smokers has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-09-21